Results from a randomized, phase 2 clinical trial show that adding high-dose, intravenous (IV) vitamin C to chemotherapy doubles the overall survival of patients with late-stage metastatic ...

A study led by Dr Joseph J. Cullen from the University of Iowa reveals that high-dose intravenous vitamin C, when combined with chemotherapy, significantly increases the survival rate for patients ...